News

Depolymerization of microtubules contributes to spontaneous neurotransmitter release

A study that reveals that microtubules, apart from their known structural role in cells, they also exert an active influence on neuronal communication.

Leer más about Depolymerization of microtubules contributes to spontaneous neurotransmitter release

Advances in the approach to multiple sclerosis, within reach of patients on World MS Day

The Neurological Diseases and Neurogenetics research group of the Bellvitge Biomedical Research Institute (IDIBELL) and the Multiple Sclerosis Unit of the Neurology Service of the HUB have co-organized this day to explain the new advances achieved in the approach and search of the disease and to give voice to patients.

Leer más about Advances in the approach to multiple sclerosis, within reach of patients on World MS Day

IDIBELL and the University of Iowa developed a new molecule for targeted treatment against cancer

It is an aptamer, a small nucleic acid molecule that specifically recognizes a receptor highly expressed in tumor cells of breast cancer, sarcoma, melanoma, and colon cancer, among others. The new molecule could be linked to cancer treatments and used as a platform for localized drug delivery that reduces side effects.

Leer más about IDIBELL and the University of Iowa developed a new molecule for targeted treatment against cancer

Bellvitge’s mHealth research stood out in the most relevant Congress of Heart Failure

The excellent results of the HERMeS clinical trial, a pioneer in the application of telemedicine and mHealth in Heart Failure, have been presented at the Heart Failure 2023 Congress, which took place between May 20 and 23 in Prague (Republic of Czech).

Leer más about Bellvitge’s mHealth research stood out in the most relevant Congress of Heart Failure

Genetically engineered stem cells to power cancer immunotherapy

The IDIBELL, the ICO, the CSIC and the Catalan Banc de Sang i Teixits sign an agreement to investigate CAR-NK cells production, which are easier to generate than the CAR-T cells that are already successfully being used in immunotherapy.

Leer más about Genetically engineered stem cells to power cancer immunotherapy

La vida en pausa, breast cancer without taboos

In 2019, Maria del Valle was diagnosed with breast cancer. In the book “La vida en pausa”, she explains her process clearly and directly. A part of the profits will go to breast cancer research at IDIBEL and ICO.

Leer más about La vida en pausa, breast cancer without taboos

DNA microsatellites instability, a possible predictor of endometrial cancer

Researchers develop a new highly-sensitive method that combines massive sequencing of the patient’s genetic material and the subsequent bioinformatics analysis that would detect changes in the DNA to predict endometrial cancer development.

Leer más about DNA microsatellites instability, a possible predictor of endometrial cancer

Personalized therapies based on the study of genetic alterations could increase the survival of nasal NK-T lymphoma

A study focused on this disease compares patients in Spain, where it is a rare disease, and the results of other studies carried out in East Asia and Latin America, where the disease is more frequent and prevalent among the population.

Leer más about Personalized therapies based on the study of genetic alterations could increase the survival of nasal NK-T lymphoma

Tanicotaki, the cookbook to raise funds for ALS reaches its second edition

Tanicotaki is the combination of Nico with Tataki, a Japanese cooking technique. And, “Tanicotaki. Cocinando sin límites” is a recipe book that reflects the passion for cooking and for being among friends and family of Nicolás Anglada Jané.

Leer más about Tanicotaki, the cookbook to raise funds for ALS reaches its second edition
Scroll to Top